Kallijarvi 2013 Abstract IOC75: Difference between revisions
Marte Verena (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary Β |
||
(8 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
{{Abstract | {{Abstract | ||
|title=Kallijarvi J (2013) Respiratory chain dysfunction in the | |title=Kallijarvi J (2013) Respiratory chain dysfunction in the Complex III assembly disorder GRACILE. Mitochondr Physiol Network 18.03. | ||
|info=[http://www.oroboros.at/index.php?id=ioc75_schroecken IOC75 Open Access] | |info=[http://www.oroboros.at/index.php?id=ioc75_schroecken IOC75 Open Access] | ||
|authors=Kallijarvi J, | |authors=Kallijarvi J, | ||
|year=2013 | |year=2013 | ||
|event=[[IOC75]] | |event=[[IOC75]] | ||
|abstract=GRACILE syndrome (Fellman disease, MIM 603358), is a neonatal mitochondrial disorder that belongs to the Finnish disease heritage. The GRACILE acronym comes from the most important clinical features of the disorder, namely fetal Growth Restriction, Aminoaciduria, Cholestasis, Iron overload, Lactic acidosis, and Early death during infancy. GRACILE is caused by a homozygous 232A>G missense mutation in the BCS1L gene. The mutation results in deficiency of respiratory | |abstract=GRACILE syndrome (Fellman disease, MIM 603358), is a neonatal mitochondrial disorder that belongs to the Finnish disease heritage. The GRACILE acronym comes from the most important clinical features of the disorder, namely fetal Growth Restriction, Aminoaciduria, Cholestasis, Iron overload, Lactic acidosis, and Early death during infancy. GRACILE is caused by a homozygous 232A>G missense mutation in the BCS1L gene. The mutation results in deficiency of respiratory Complex III (CIII, ubiquinol-cytochrome c reductase) and result in death during infancy. Other BCS1L mutations have been associated with a wide spectrum of phenotypes, ranging from mild congenital neurosensory hearing loss and distorted hair to tubulopathy alone, or combined with hepatopathy. BCS1L is a nuclear gene that encodes a mitochondrial AAA-family ATPase. There is strong evidence that it acts as a chaperone that incorporates the Rieske iron-sulfur protein (RISP) into CIII. The GRACILE mutation is situated in the N-terminal import region, and when introduced into yeast bcs1 results in lack of CIII function. We have generated a knock-in mouse model for GRACILE. The main findings in the homozygous mice are growth restriction and progressive liver disorder from the fourth week of life, tubulopathy and death before 6 weeks of age of most of the animals. RISP incorporation into complex III is diminished in symptomatic animals; however, in young animals complex III is correctly assembled. CIII activity in liver, heart, and kidney of symptomatic mutants is decreased to 20%, 40%, and 40% of controls, respectively. In high-resolution respirometry analysis of liver mitochondria from sick mice, CIII dysfunction results in decreased electron transport capacity through the respiratory chain under maximum substrate input. In line with this, tolerance of mitochondrial respiration to complex III inhibition by myxothiazol decreases with age in GRACILE mouse tissues. However, in patient fibroblasts no alterations in RC activity are detected by respirometry. | ||
Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO (1998). Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 351: 490-493. | Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO (1998). Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 351: 490-493. | ||
Line 15: | Line 15: | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
| | |area=Genetic knockout;overexpression | ||
|organism=Human, Mouse | |organism=Human, Mouse | ||
|tissues=Liver, Kidney, Fibroblast | |||
|tissues=Liver, Kidney | |preparations=Isolated mitochondria | ||
|preparations=Isolated | |||
|enzymes=Complex III | |enzymes=Complex III | ||
|topics=Substrate | |topics=ATP, Substrate, Fatty acid | ||
|instruments=Oxygraph-2k | |||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
Line 51: | Line 49: | ||
== Help == | == Help == | ||
* [[Abstracts IOC help]] | * [[Abstracts IOC help]] | ||
* [[MitoPedia | * [[MitoPedia: Terms and abbreviations]] |
Latest revision as of 15:37, 9 November 2016
Kallijarvi J (2013) Respiratory chain dysfunction in the Complex III assembly disorder GRACILE. Mitochondr Physiol Network 18.03. |
Link: IOC75 Open Access
Kallijarvi J (2013)
Event: IOC75
GRACILE syndrome (Fellman disease, MIM 603358), is a neonatal mitochondrial disorder that belongs to the Finnish disease heritage. The GRACILE acronym comes from the most important clinical features of the disorder, namely fetal Growth Restriction, Aminoaciduria, Cholestasis, Iron overload, Lactic acidosis, and Early death during infancy. GRACILE is caused by a homozygous 232A>G missense mutation in the BCS1L gene. The mutation results in deficiency of respiratory Complex III (CIII, ubiquinol-cytochrome c reductase) and result in death during infancy. Other BCS1L mutations have been associated with a wide spectrum of phenotypes, ranging from mild congenital neurosensory hearing loss and distorted hair to tubulopathy alone, or combined with hepatopathy. BCS1L is a nuclear gene that encodes a mitochondrial AAA-family ATPase. There is strong evidence that it acts as a chaperone that incorporates the Rieske iron-sulfur protein (RISP) into CIII. The GRACILE mutation is situated in the N-terminal import region, and when introduced into yeast bcs1 results in lack of CIII function. We have generated a knock-in mouse model for GRACILE. The main findings in the homozygous mice are growth restriction and progressive liver disorder from the fourth week of life, tubulopathy and death before 6 weeks of age of most of the animals. RISP incorporation into complex III is diminished in symptomatic animals; however, in young animals complex III is correctly assembled. CIII activity in liver, heart, and kidney of symptomatic mutants is decreased to 20%, 40%, and 40% of controls, respectively. In high-resolution respirometry analysis of liver mitochondria from sick mice, CIII dysfunction results in decreased electron transport capacity through the respiratory chain under maximum substrate input. In line with this, tolerance of mitochondrial respiration to complex III inhibition by myxothiazol decreases with age in GRACILE mouse tissues. However, in patient fibroblasts no alterations in RC activity are detected by respirometry.
Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO (1998). Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 351: 490-493.
Kotarsky H, Karikoski R, Morgelin M, Marjavaara S, Bergman P, Zhang DL et al (2010). Characterization of complex III deficiency and liver dysfunction in GRACILE syndrome caused by a BCS1L mutation. Mitochondrion 10: 497-509.
Leveen P, Kotarsky H, Morgelin M, Karikoski R, Elmer E, Fellman V (2011). The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: a viable mouse model for mitochondrial hepatopathy. Hepatology 53: 437-447.
β’ Keywords: BCS1L, GRACILE, CIII, Rieske, hepatopathy
Labels: MiParea: Genetic knockout;overexpression
Organism: Human, Mouse
Tissue;cell: Liver, Kidney, Fibroblast
Preparation: Isolated mitochondria
Enzyme: Complex III
Regulation: ATP, Substrate, Fatty acid
HRR: Oxygraph-2k
Affiliations and author contributions
Jukka KallijΓ€rvi, Prof. Vineta Fellman:
FolkhΓ€lsan Research Center Biomedicum C314a P.O.Box 63 (Haartmaninkatu 8) FI-00014 University of Helsinki Finland
Vineta Fellman:
Professor of neonatology Department Head Department of Pediatrics Lund University 22185 Lund Sweden